Survodutide
SYNCHRONIZE™JP
Boehringer Ingelheim · Phase 3 · Completed · Enrollment 274
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Survodutide
Boehringer Ingelheim · Phase 3 · Completed · Enrollment 274
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.